glp-1 agonist cardiovascular outcomes

glp-1 agonist cardiovascular outcomes and mortality with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Cardiovascular, mortality, and kidney outcomes

Name: glp-1 agonist cardiovascular outcomes and mortality with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Cardiovascular, mortality, and kidney outcomes
Brand: roaa.app
SKU: 36647770752
Price: 27.15 USD
Availability: InStock
Rating: 4.6606000000000005 (5 reviews)

SKU: 36647770752

4.7

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

Some studies have proven that GLP-1RAs have favorable anabolic effects on skeletal metabolism, but underlying molecular mechanism remains to be elucidated

Volume: 30g

Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model